The 2026 Life Settlement Market: Where Pricing Models Diverge

By the InsuriShield Analytics Desk

For most of the past decade, traditional actuarial pricing and machine-learning valuation models told roughly the same story about any given policy. They disagreed at the margins — a point of IRR here, a few months of life expectancy there — but a buyer could quote either number without changing the outcome of a deal. That era is ending. Across roughly 12,000 valuations processed through our platform since January 2024, the spread between traditionally derived prices and ML-driven prices has widened steadily, and in some policy segments it is now large enough to decide who wins the trade.

What we measured

Every policy that moves through our platform can be valued two ways: a hands-on reconstruction of the policy's mechanics from its documents — the approach our expert-led PRO assessments use — and a predictive estimate from machine-learning models trained on more than one million policy data points. Because both valuations sit in the same system with the same inputs, we can observe exactly where, and by how much, they part company.

On the median policy, the two approaches still land within a few percent of each other. The interesting story is in the tails. By early 2026, one valuation in six showed a divergence of more than ten percent of face-adjusted value — nearly double the rate we observed two years ago.

Where the models disagree

• Advanced-age insureds with recent medical data. Mortality improvement at ages 85+ continues to outrun the assumptions embedded in legacy tables, and models trained on current lives price that improvement faster than annually revised tables do.
• Policies with a history of COI repricing. Carriers that have already raised cost-of-insurance rates behave differently from carriers that haven't. Pattern-aware models treat repricing history as a signal; most traditional frameworks treat each schedule as given.
• Structurally complex policies. Shadow accounts, loan offsets, and secondary guarantees produce path-dependent outcomes where small assumption changes compound — precisely where single-scenario projection is weakest.

“When two defensible models disagree by ten percent, the spread itself is the market. The buyers who understand why the models diverge are the ones who get to choose which side of the spread to stand on.”

What it means for institutional buyers

A widening model spread is not noise — it is information about where conviction is being mispriced. Portfolios assembled on purely traditional assumptions are increasingly likely to overpay for structurally complex policies and underbid policies on healthy, advanced-age insureds. Conversely, leaning on predictive estimates alone leaves money on the table whenever a full document reconstruction reveals mechanics the summary data cannot.

Our view is that the divergence is a feature to be exploited, not a discrepancy to be averaged away. Use instant predictive valuations to triage and prioritize at scale; use expert document-level reconstruction where the model flags disagreement. The spread tells you exactly where the second look pays for itself.

• Re-underwrite legacy longevity assumptions on insureds over 85 — that is where mispricing concentrates.
• Treat carrier COI history as a pricing input, not a footnote.
• Route high-divergence policies to full document-level review before bidding.

InsuriShield analyses are mathematically derived and provided for informational purposes — they are not legal, financial, or medical advice.